Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ak 3012 (1 trial)
Keratosis (Phase 2)
Keratosis, Actinic (Phase 2)
Trials (1 total)
Trial APIs (1 total)